Last update 10 Apr 2026

M3i

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
EP102
Target
METTL3
Action
inhibitors
Mechanism
METTL3 inhibitors(methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesEndocrinology and Metabolic Disease+ [3]
Active Indication
Advanced Malignant Solid NeoplasmB-Cell LymphomaOvarian Cancer+ [1]
Inactive Indication-
Originator Organization
Epics Therapeutics SAEpics Therapeutics SA
Active Organization
Epics Therapeutics SAEpics Therapeutics SA
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with M3i
CTIS2025-521305-40-00
/ RecruitingPhase 1
A study to test the safety and efficacy of EP102 in patients with advanced solid tumours
100 Clinical Results associated with M3i
Login to view more data
100 Translational Medicine associated with M3i
Login to view more data
100 Patents (Medical) associated with M3i
Login to view more data
100 Deals associated with M3i
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
Belgium
Epics Therapeutics SAEpics Therapeutics SA
22 Jul 2025
Advanced Malignant Solid NeoplasmPhase 1
Czechia
Epics Therapeutics SAEpics Therapeutics SA
22 Jul 2025
Advanced Malignant Solid NeoplasmPhase 1
France
Epics Therapeutics SAEpics Therapeutics SA
22 Jul 2025
Advanced Malignant Solid NeoplasmPhase 1
Netherlands
Epics Therapeutics SAEpics Therapeutics SA
22 Jul 2025
Advanced Malignant Solid NeoplasmPhase 1
Spain
Epics Therapeutics SAEpics Therapeutics SA
22 Jul 2025
B-Cell LymphomaPreclinical
Belgium
Epics Therapeutics SAEpics Therapeutics SA
29 Apr 2025
Ovarian CancerPreclinical
Belgium
Epics Therapeutics SAEpics Therapeutics SA
29 Apr 2025
Triple Negative Breast CancerPreclinical
Belgium
Epics Therapeutics SAEpics Therapeutics SA
29 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free